CD19 and lung cancer: However, KEGG-pathway over-representation analyses using validated target genes of the cell type specific miRNAs revealed the most significant KEGG pathways for CD3+ T-cells in lung cancer patient samples and for CD19+ B-cells in samples from healthy individuals.